Kun He

发表

Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.

Jiali Chen, Kun He, Yunwei Han, 2022, Annals of hepatology.

Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma

Jie Zhou, Kun He, Shibo Sun, 2016, Oncology research.

Advanced oxidation protein products induce hepatocyte epithelial–mesenchymal transition via a ROS‐dependent, TGF‐β/Smad signaling pathway

Qifan Zhang, Jie Zhou, Kun He, 2017, Cell biology international.

A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma

Kun He, J. Qian, P. Peng, 2021, Scientific Reports.

CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

Kun He, Jingdong Li, Mengyi Xie, 2022, International journal of general medicine.

Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.

Kun He, Y. He, Ruiqin Huang, 2020, Annals of hepatology.

Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study

Jie Zhou, Kun He, Shibo Sun, 2016, SpringerPlus.

Elucidation of the Mechanisms and Molecular Targets of Shuanglian Decoction for the Treatment of Hepatocellular Carcinoma Based on Network Pharmacology

Kun He, Jiantao Lin, Hua Chen, 2020, ACS omega.

EHHM, a novel phenolic natural product from Livistona chinensis, induces autophagy-related apoptosis in hepatocellular carcinoma cells

Jie Zhou, Kun He, Shibo Sun, 2016, Oncology letters.

MicroRNA301 is a potential diagnostic biomarker for hepatocellular cancer.

Jie Zhou, Kun He, Shibo Sun, 2015, International journal of clinical and experimental pathology.

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma

Kun He, Zelong Yang, Xinyu Liu, 2023, Journal of hepatocellular carcinoma.

Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China

Kun He, Yuanpeng Xiong, Yong Li, 2023, BMC Cancer.

Comparison of short- and long-term therapeutic effects of laparoscopic and open-type hepatectomy for primary hepatic carcinoma

Dong-Dong Huang, Kun He, Xueyi Gong, 2017 .

Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort

L. Luo, Liping Liu, Renfeng Shan, 2023, United European gastroenterology journal.

Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study

Kun He, Yunwei Han, Lu Guo, 2023, Journal of Cancer Research and Clinical Oncology.